IU-Lilly study to explore drugs’ impact on job productivity
Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on weight loss drugs, including Lilly medications.
Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on weight loss drugs, including Lilly medications.
The rise of artificial intelligence is not only affecting how people work—it’s also shaping the job market itself, especially for graduates in search of their first professional jobs.
City leaders, local companies and food banks have teamed up to create a $1 million-plus partnership and fundraising push to help more than 200 food pantries in Indianapolis.
With quarterly revenue up 54% from a year ago, Eli Lilly raised it guidance for the year, with the company now expecting revenue in the range of $63 billion to $63.5 billion.
Through its LillyDirect pharmacy, Eli Lilly plans to offer steep discounts on single-dose vials of Zepbound by partnering with the nation’s largest retail chain.
Indianapolis-based Eli Lilly and Co. said the improved facility in Carolina, Puerto Rico, will make orforglipron, Lilly’s highly anticipated weight loss pill.
The Indianapolis-based drugmaker said the supercomputer will power an “AI factory” designed to accelerate drug discovery and development.
Heartland BioWorks was designated as a federal technology hub by the U.S. Department of Commerce in October 2023 to support growth in biomanufacturing innovation and workforce development.
Purdue University’s new Center for Musculoskeletal Engineering in Indianapolis has a growth plan that metaphorically matches a healthy growing body.
Local and federal funds, special state appropriations, private and philanthropic investments, and innovative value-capture mechanisms must all be considered.
The move continues the Indianapolis-based drugmaker’s investments in age-related diseases.
Per the agreement, the Indianapolis-based drugmaker will continue to manufacture the drug, which India-based Cipla will sell under a new brand name.
The restaurant will be a sibling business of Aroma Experience, which opened in 2024 as part of the Carmel City Center development.
The signatures of President Vop Osili and several other councilors were missing from a letter released last week.
Some Hoosier employers are freezing efforts to recruit H-1B workers because they don’t know if the federal government will apply the $100,000 fee to certain applicants.
Indiana’s growing partnership with Portugal includes imports like rubber, plastics and chemicals, the latter of which is driven largely by pharmaceuticals, according to a Portuguese trade representative.
More than half of the 25-member Indianapolis City-County Council signed a public letter opposing the proposed deal, saying AES Indiana “continues to fall short on service.”
As Elanco Animal Health Inc. settles into its new home in Indianapolis, leaders in Greenfield have turned their attention to the future of the company’s former corporate campus.
The Lebanon-based hospital faces increased competition from large health systems that benefit from larger economies of scale and marketing budgets.
Mehmet Oz, head of the Centers for Medicare and Medicaid Services, said talks over the price of weight-loss drugs are still ongoing.